AMICUS THERAPEUTICS, INC. — Director's Dealing 2015

May 12, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-05-08

Reporting Person: Campbell Bradley L (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-08	Common stock	M	50000	—	Acquired	50000	Direct
2015-05-08	Common stock	F	18625	$10.80	Disposed	31375	Direct
2015-05-11	Common stock	S	24800	$10.8391	Disposed	6575	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-08	Restricted stock units	$	M	50000	Disposed		Common Stock (50000)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: The sale of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2014.

F3: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.71 to $11.00. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: On April 10, 2014, the reporting person was granted 100,000 restricted stock units, vesting in equal installments of 50,000 restricted stock units on May 10, 2015 and 50,000 restricted stock units on December 3, 2015.